Mercury Systems (NASDAQ:MRCY) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.21 by 14.29 percent. This is a 41.46 percent decrease over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $266.90 million which beat the analyst consensus estimate of $217.92 million by 22.48 percent. This is a 18.62 percent increase over sales of $225.01 million the same period last year.
Windtree Therapeutics Has Been Granted U.S. Patent Number 11,583,540 Titled “Istaroxime-Containing Intravenous Formulation For The Treatment Of Acute Heart Failure”
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11583540).pn
